Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose vaginal estrogens in breast cancer patients with urogenital atrophy
2010-024603-26Phase 2Terminated
- Sponsor
- European Institute of Oncology
- Start
- Mar 2012
- Countries
- 1
01
Overview
Phase 2, single-arm trial of estradiol in vaginal atrophy and breast cancer, sponsored by European Institute of Oncology. Primary endpoint: Primary: Maintenance of serum estradiol levels in postmenopausal range. Started Mar 2012; status: terminated.
02
Drugs
estradiol
03
Conditions
vaginal atrophybreast cancer
Beyond the preview
Go deeper on 2010-024603-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024603-26.